Streetbeat News

Stock Prices

KMX

CarMax (NYSE:KMX) has been analyzed by 13 analysts, revealing a range of sentiments from bullish to bearish. The average 12-month price target is $80.23, with a high of $105.00 and a low of $66.00. Recent analyst actions include maintaining, raising, and lowering ratings and price targets. CarMax's financial performance shows a decline in revenue growth but strong net margin, ROE, and ROA. The company's debt-to-equity ratio is below the industry average.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 6:00 pm

LLY

NVO

Doctors are facing challenges in securing Medicare coverage for Novo Nordisk's weight-loss drug Wegovy, despite its potential benefits for heart patients. Medicare's legal restrictions on covering weight-loss drugs and the high cost of Wegovy are significant barriers. Novo Nordisk is working with policymakers to improve coverage, and there is hope for better coverage next year. Eli Lilly's obesity drug Zepbound may also impact the market if it gains FDA approval for treating obstructive sleep apnea.

Portfolio Pulse from Vandana Singh

August 16, 2024 | 5:59 pm

SBUX

Recent options trading activity indicates a bullish sentiment among large investors for Starbucks (NASDAQ:SBUX). Benzinga's options scanner identified 30 significant trades, with 66% being bullish. The trades suggest a price range of $70 to $110 for SBUX over the next three months. Analysts have also provided positive ratings, with target prices ranging from $105 to $120.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 5:46 pm

Deep-pocketed investors have shown unusual options activity for Morgan Stanley (NYSE:MS), with a mix of bullish and bearish sentiments. Significant options trades include both puts and calls, suggesting a price target range of $60.0 to $100.0. The stock is currently down 0.26% at $100.38.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 5:46 pm

SPY

Federal Reserve's Goolsbee has issued a warning about increasing small business defaults and rising unemployment, which have now reached cautionary levels. This could signal potential economic challenges ahead.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 5:41 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) shares surged by 65.4% following the WHO's declaration of mpox as a global health emergency and the ECDC's new risk assessment. The ECDC recommends heightened preparedness and rapid response measures in the EU/EEA due to the risk of imported mpox cases from Africa.

Portfolio Pulse from Vaishali Prayag

August 16, 2024 | 5:40 pm

AMAT

AMCR

COHR

DIA

FLO

GDX

GLOB

HRB

IWM

MRVI

QQQ

RGEN

SPY

XLC

XLF

XLRE

XLY

Wall Street saw modest gains on Friday, driven by improved consumer sentiment and strong economic data. Gold hit a record high, boosting mining stocks, while oil prices dipped due to geopolitical developments. Key ETFs and stocks showed varied performances, with notable movements in H&R Block, Amcor, Applied Materials, Coherent, Flower Foods, Globant, and Repligen.

Portfolio Pulse from Piero Cingari

August 16, 2024 | 5:38 pm

AFRM

CME

COIN

CRBG

ICE

RILY

UPST

Today's session saw significant options activity involving several financial stocks. Notable transactions include bullish call sweeps for AFRM, FI, ICE, and CME, and bearish call sweeps for GS, CRBG, RILY, UPST, and SQ. COIN saw a bullish put trade.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 5:35 pm

AAPL

AMD

DELL

INTC

MCHP

MSFT

NVDA

PLTR

SKYT

TSM

The article highlights significant options activity in the Information Technology sector, focusing on trades involving companies like AAPL, MSFT, NVDA, AMD, INTC, TSM, DELL, SKYT, PLTR, and MCHP. These activities could indicate potential trading opportunities based on the sentiment and volume of the trades.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 5:35 pm

TNXP

Tonix Pharmaceuticals' live virus vaccine candidate, TNX-801, shows long-term protection from mpox and smallpox with a single dose in animal studies. The company is advancing its development, and the vaccine has been selected by the NIH for Project NextGen. The stock saw a 4.01% increase, trading at $0.48.

Portfolio Pulse from Vandana Singh

August 16, 2024 | 5:29 pm